Whalegun
Home

Kevin Charles Gorman, CEO: Neurocrine Biosciences NBIX Sell · Filed 23/02/08

Trade details

Type
Insider sale
Amount
$2,097,971.26
Shares · price
20,482 sh · $102.43 a share
Held after
489,322 sh
Stock
Neurocrine Biosciences NBIX
Person
Kevin Charles GormanCEO
Trade date
23/02/07
Filed
23/02/08
Days to filing
1 days

Sold 4.0% of holdings

Share of holding sold
4.0%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 23/01/08~23/03/09

Kevin Charles Gorman's recent trades

  • Kevin Charles Gorman

    Sell10b5-1 planXencor

    $92.7K

    Filed 06/17

  • Kevin Charles Gorman

    Planned sale10b5-1 planXencor

    $92.7K

    Filed 06/15

  • Kevin Charles Gorman

    Sell10b5-1 planNeurocrine Biosciences

    $37.8M

    Filed 05/21

  • Kevin Charles Gorman

    Planned sale10b5-1 planNeurocrine Biosciences

    $38.5M

    Filed 05/19

  • Kevin Charles Gorman

    Sell10b5-1 planNeurocrine Biosciences

    $13.4M

    Filed 25/08/11

Kevin Charles Gorman, CEO — sold $2.1M of Neurocrine Biosciences NBIX · 4.0% of holdings | Whalegun